Literature DB >> 15787741

Mycobacterium avium ssp. paratuberculosis recombinant heat shock protein 70 interaction with different bovine antigen-presenting cells.

M F M Langelaar1, J C Hope, V P M G Rutten, J P T M Noordhuizen, W van Eden, A P Koets.   

Abstract

Abstract Heat shock proteins (Hsp) can deliver antigen into the major histocompatibility complex class I presentation pathway of antigen-presenting cells (APC), a process called cross priming, thus stimulating antigen-specific CD8+ T-cell reactions. Hsp were shown to elicit proinflammatory responses in APC. Both processes require interaction of Hsp with APC via specific receptors. This study describes the interaction of recombinant Hsp70 (rHsp70) of Mycobacterium avium subspecies paratuberculosis with bovine peripheral blood mononuclear cells that was restricted to CD14+ cells. Characterized monocyte-derived macrophages, monocyte-derived dendritic cells (DC) and BoMac, an immortalized bovine macrophage cell line, were used to investigate the interaction of rHsp70 with different bovine APC. Saturation of immature DC with high concentrations of rHsp70 is demonstrated, and it was found that interaction of rHsp70 with DC was related to the maturation stage of the DC. Involvement of CD91 as a cellular receptor for rHsp70 was demonstrated; however, competition studies with immature DC demonstrated that other receptors exist on bovine APC. These data suggest that rHsp70-based vaccines may be useful for the successful immunization of cattle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15787741     DOI: 10.1111/j.1365-3083.2005.01559.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Live Mycobacterium avium subsp. paratuberculosis and a killed-bacterium vaccine induce distinct subcutaneous granulomas, with unique cellular and cytokine profiles.

Authors:  Liying Lei; Brandon L Plattner; Jesse M Hostetter
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

2.  Mycobacterium tuberculosis heat-shock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro.

Authors:  Adriana Motta; Carla Schmitz; Luiz Rodrigues; Flávia Ribeiro; Cesar Teixeira; Thiago Detanico; Carla Bonan; Heather Zwickey; Cristina Bonorino
Journal:  Immunology       Date:  2007-03-07       Impact factor: 7.397

3.  Primary transcriptomes of Mycobacterium avium subsp. paratuberculosis reveal proprietary pathways in tissue and macrophages.

Authors:  Harish K Janagama; Elise A Lamont; Sajan George; John P Bannantine; Wayne W Xu; Zheng J Tu; Scott J Wells; Jeremy Schefers; Srinand Sreevatsan
Journal:  BMC Genomics       Date:  2010-10-12       Impact factor: 3.969

4.  Application of antibodies to recombinant heat shock protein 70 in immunohistochemical diagnosis of mycobacterium avium subspecies paratuberculosis in tissues of naturally infected cattle.

Authors:  Julius Boniface Okuni; David Patrick Kateete; Moses Okee; Anna Nanteza; Moses Joloba; Lonzy Ojok
Journal:  Ir Vet J       Date:  2017-03-24       Impact factor: 2.146

5.  CD91-Dependent Modulation of Immune Responses by Heat Shock Proteins: A Role in Autoimmunity.

Authors:  Robert J Binder; Yu Jerry Zhou; Michelle N Messmer; Sudesh Pawaria
Journal:  Autoimmune Dis       Date:  2012-11-19

6.  Cytokine responses of bovine macrophages to diverse clinical Mycobacterium avium subspecies paratuberculosis strains.

Authors:  Harish K Janagama; Kwang il Jeong; Vivek Kapur; Paul Coussens; Srinand Sreevatsan
Journal:  BMC Microbiol       Date:  2006-02-14       Impact factor: 3.605

7.  Screening of Mycobacterium avium subsp. paratuberculosis mutants for attenuation in a bovine monocyte-derived macrophage model.

Authors:  Elise A Lamont; Adel M Talaat; Paul M Coussens; John P Bannantine; Yrjo T Grohn; Robab Katani; Ling-ling Li; Vivek Kapur; Srinand Sreevatsan
Journal:  Front Cell Infect Microbiol       Date:  2014-06-30       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.